John A. Lawson

Active 1974–2024

101
Papers
18,686
Citations
80
h-index
100
i10-index

Citations

Citations per year for John A. Lawson1982: 1 citations1983: 6 citations1984: 6 citations1985: 11 citations1986: 21 citations1987: 15 citations1988: 16 citations1989: 12 citations1990: 12 citations1991: 21 citations1992: 12 citations1993: 13 citations1994: 9 citations1995: 8 citations1996: 20 citations1997: 62 citations1998: 121 citations1999: 169 citations2000: 193 citations2001: 223 citations2002: 164 citations2003: 254 citations2004: 178 citations2005: 222 citations2006: 202 citations2007: 180 citations2008: 195 citations2009: 158 citations2010: 132 citations2011: 153 citations2012: 125 citations2013: 118 citations2014: 120 citations2015: 112 citations2016: 104 citations2017: 118 citations2018: 123 citations2019: 399 citations2020: 420 citations2021: 420 citations2022: 345 citations2023: 236 citations2024: 311 citations2025: 147 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,020 citing papers, 30.2% of this breakdownItaly: 507 citing papers, 7.6% of this breakdownUnited Kingdom: 496 citing papers, 7.4% of this breakdownGermany: 378 citing papers, 5.6% of this breakdownFrance: 313 citing papers, 4.7% of this breakdownChina: 294 citing papers, 4.4% of this breakdownAustralia: 261 citing papers, 3.9% of this breakdownCanada: 248 citing papers, 3.7% of this breakdownNetherlands: 193 citing papers, 2.9% of this breakdownJapan: 190 citing papers, 2.8% of this breakdownSpain: 163 citing papers, 2.4% of this breakdownSweden: 124 citing papers, 1.9% of this breakdown
0%30.2%Other 22.5%

Fields

  • Medicine62.3%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Neuroscience8.1%
  • Nursing3.3%
  • Immunology and Microbiology1.6%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Other3.3%

Topics

  • Inflammatory mediators and NSAID effects5.6%
  • Eicosanoids and Hypertension Pharmacology4.4%
  • Epilepsy research and treatment3.9%
  • Antioxidant Activity and Oxidative Stress3.4%
  • Antiplatelet Therapy and Cardiovascular Diseases2.4%
  • Tuberous Sclerosis Complex Research2.2%
  • Other78.1%

Coauthors

All papers

Open in search
  1. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

    Authors: , , , , , , , , , , , , , - The Lancet 2016 cited by 747

  2. Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charuta Joshi, Sergiusz Jóźwiak, Pavel Klein, Katarzyna Kotulska, Patrick Kwan, John A. Lawson, Paweł Lisewski, Ian Miller, Richard P. Morse, Ali S. Mostajelean, Danielle Nolan, Terence J. O’Brien, Finbar O’Callaghan, Fernando Paredes, Μ. Scott Perry, Federico Ramos, David C. Reutens, Colin Roberts, Russell P. Saneto, Gregory B. Sharp, Anurag Saxena, Steven Sparagana, Priyamvada Tatachar, Elizabeth A. Thiele, James W. Wheless, Elaine Wirrell, Matthew H. Wong, Michael Wong, Joyce Y. Wu, Marta Żołnowska - JAMA Neurology 2020 cited by 262

  3. Obesity in mice with adipocyte-specific deletion of clock component Arntl

    Authors: , , , , , , , , , , , , , - Nature Medicine 2012 cited by 462

  4. GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Levinus A. Bok, Rikke S. Møller, Uffe Birk Jensen, J Gordon Millichap, Anne T. Berg, Ethan M. Goldberg, Isabelle De Bie, Stéphanie Fox, Philippe Major, Julie R. Jones, Elaine H. Zackai, Rami Abou Jamra, Arndt Rolfs, Richard J. Leventer, John A. Lawson, Tony Roscioli, Floor E. Jansen, Emmanuelle Ranza, Christian Korff, Anna-Elina Lehesjoki, Carolina Courage, Tarja Linnankivi, Douglas R Smith, Christine M. Stanley, Mark Mintz, Dianalee McKnight, Amy Decker, Wen‐Hann Tan, Mark A. Tarnopolsky, Lauren Brady, Markus Wolff, Lutz Dondit, Hélio Pedro, Sarah Parisotto, Kelly L. Jones, Anup D. Patel, David Neal Franz, Rena Vanzo, Elysa Marco, Judith D. Ranells, Nataliya Di Donato, William B. Dobyns, Bodo Laube, Stephen F. Traynelis, Johannes R. Lemke - Journal of Medical Genetics 2017 cited by 256

  5. Prostaglandin D 2 Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia

    Authors: , , , , , , , , , , , , , , - Science Translational Medicine 2012 cited by 299

  6. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Epilepsia Open 2018 cited by 238

  7. Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2021 cited by 95

  8. Bioactive products formed in humans from fish oils

    Authors: , , , , , , - Journal of Lipid Research 2015 cited by 109

  9. Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick B. Walter, K. B. Tomer, Ronald P. Mason, J. Carl Barrett - Free Radical Biology and Medicine 2004 cited by 694

  10. Everolimus for treatment-refractory seizures in TSC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Vallée, Sylvie Nguyen The Tich, Mathieu Milh, Anne de Saint Martin, Patrick Berquin, Dorothée Ville, Adelheid Wiemer‐Kruel, Christoph Hertzberg, Gert Wiegand, Tilman Polster, Antigone Papavasiliou, Meropi Tzoufi, András Fogarasi, Zsuzsanna Gyorsok, Péter Diószeghy, David William Webb, G. Bartalini, Giuseppe Gobbi, Maria Paola Canevini, Pierangelo Veggiotti, M. G. Baglietto, Anna Teresa Giallonardo, Nicola Laforgia, Raffaele Falsaperla, Hiroko Ikeda, Shin Nabatame, Hisashi Kawawaki, Harumi Yoshinaga, Masaya Kubota, Yasuhiro Suzuki, Hugo Ceja Moreno, Bernard A. Zonnenberg, Marie‐Claire Y. de Wit, Marian Majoie, Marit Bjoernvold, Sergiusz Jóźwiak, Kijoong Kim, Heung Dong Kim, Munhyang Lee, Taesung Ko, Elena Belousova, Nataliya A. Ermolenko, И. Е. Повереннова, Liudmila Kuzenkova, Maria Luz Ruiz Falco Rojas, Adolfo López de Munaín, Juan Rodríguez Uranga, Vicente Villanueva, Pi‐Chuan Fan, Chao Huang, Ying‐Chao Chang, Charcrin Nabangchang, Krisnachai Chomtho, Surachai Likasitwattanakul, Lunliya Thampratankul, Zühal Yapıcı, Ayşe Serdaroğlu, Banu Ahlar, Sarah Aylett, Archana Desurkar, Clare Johnston, Matthias J. Koepp, Hannah R. Cock, Alasdair Parker, Dougall McCorry, Richard Appleton, Steven Sparagana, Katherine S. Taub, Michael Frost, Colin Roberts and 18 more - Neurology Clinical Practice 2018 cited by 107

  11. Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2

    Authors: , , , , , , , - Science 2002 cited by 791

  12. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.

    Authors: , , , - Journal of Clinical Investigation 1997 cited by 482

  13. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Genetics & Genomic Medicine 2018 cited by 113

  14. DNM1 encephalopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernd A. Neubauer, Hiltrud Muhle, Ulrich Stephani, Ingrid E. Scheffer, Sérgio D.J. Pena, Sanjay M. Sisodiya, Ingo Helbig, For the EuroEPINOMICS-RES NLES Working Group - Neurology 2017 cited by 113

  15. COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice

    Authors: , , , , , , - Science 2004 cited by 426

  16. 12/15-Lipoxygenase Is Increased in Alzheimer's Disease

    Authors: , , , , , , , - American Journal Of Pathology 2004 cited by 242

  17. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bregje W.M. van Bon, Joanna Kennedy, Karen Low, Sian Ellard, Lewis Pang, Joseph Junewick, Paul R. Mark, Gemma L. Carvill, Geoffrey T. Swanson - The American Journal of Human Genetics 2021 cited by 51

  18. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial

    Authors: , , , , , , , - Epilepsia 2022 cited by 35

  19. TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Orphanet Journal of Rare Diseases 2017 cited by 283

  20. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Orphanet Journal of Rare Diseases 2018 cited by 191

  21. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial

    Authors: , , , , , , , , , , , , , - The Lancet Child & Adolescent Health 2018 cited by 116

  22. Ten-Year Single-Center Experience of the Ketogenic Diet: Factors Influencing Efficacy, Tolerability, and Compliance

    Authors: , , , , , , - The Journal of Pediatrics 2015 cited by 83

  23. Adjunctive everolimus therapy for tuberous sclerosis complex‐associated refractory seizures: Results from the postextension phase of EXIST‐3

    Authors: , , , , , , , , , , , , - Epilepsia 2021 cited by 43

  24. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 1,308